These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Can exercise replace airway clearance techniques in cystic fibrosis? A survey of patients and healthcare professionals. Rowbotham NJ; Smith SJ; Davies G; Daniels T; Elliott ZC; Gathercole K; Rayner OC; Smyth AR J Cyst Fibros; 2020 Jul; 19(4):e19-e24. PubMed ID: 31740105 [TBL] [Abstract][Full Text] [Related]
36. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis. Westhölter D; Beckert H; Straßburg S; Welsner M; Sutharsan S; Taube C; Reuter S J Cyst Fibros; 2021 Nov; 20(6):1072-1079. PubMed ID: 34030985 [TBL] [Abstract][Full Text] [Related]
37. A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators. Kramer-Golinkoff E; Camacho A; Kramer L; Taylor-Cousar JL Pediatr Pulmonol; 2022 May; 57(5):1253-1261. PubMed ID: 35170259 [TBL] [Abstract][Full Text] [Related]
38. Timing of hypertonic saline inhalation for cystic fibrosis. Elkins M; Dentice R Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008816. PubMed ID: 28146603 [TBL] [Abstract][Full Text] [Related]
39. Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators. Britto CJ; Ratjen F; Clancy JP Clin Chest Med; 2022 Dec; 43(4):631-646. PubMed ID: 36344071 [TBL] [Abstract][Full Text] [Related]